Along these lines, we previously documented using in vivo approaches and transfer models with wild transgenic and reporter mice that even during colitis T cells can convert into Foxp3+ T cells within the colon mucosa, thus retaining an in vivo suppressive function alleviating colitis (10). This evidence concerns the gene FOXP3 and colitis.